We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCO icon
251
Moody's
MCO
$82.8B
$747K 0.03%
2,573
-75
-3% -$21K
OPLN
252
Openlane
OPLN
$4.58B
$616K 0.02%
33,092
-9,445
-22% -$163K
JAZZ icon
253
Jazz Pharmaceuticals
JAZZ
$16.7B
$593K 0.02%
3,595
-53,351
-94% -$7.95M
IWC icon
254
iShares Micro-Cap ETF
IWC
$1.49B
$587K 0.02%
+4,951
New +$523K
MRK icon
255
Merck
MRK
$323B
$584K 0.02%
7,488
– –
PEP icon
256
PepsiCo
PEP
$188B
$561K 0.02%
3,782
– –
SYY icon
257
Sysco
SYY
$40.1B
$554K 0.02%
7,461
-9,700
-57% -$667K
CAG icon
258
Conagra Brands
CAG
$7.07B
$481K 0.02%
13,275
-50
-0.4% -$1.81K
PG icon
259
Procter & Gamble
PG
$340B
$454K 0.02%
3,264
– –
WMT icon
260
Walmart Inc
WMT
$897B
$442K 0.02%
9,198
-3,000
-25% -$146K
J icon
261
Jacobs Solutions
J
$17.2B
$431K 0.02%
4,778
-3,971
-45% -$337K
LLY icon
262
Eli Lilly
LLY
$1.1T
$420K 0.01%
2,490
– –
XOM icon
263
ExxonMobil
XOM
$662B
$413K 0.01%
10,023
-848
-8% -$31.8K
CVX icon
264
Chevron
CVX
$382B
$392K 0.01%
4,643
-1,374
-23% -$111K
WDFC icon
265
WD-40
WDFC
$3.15B
$385K 0.01%
1,450
– –
LAD icon
266
Lithia Motors
LAD
$8.35B
$375K 0.01%
1,282
– –
BRK.A icon
267
Berkshire Hathaway Class A
BRK.A
$1.14T
$348K 0.01%
1
– –
COHR icon
268
Coherent
COHR
$63.6B
$343K 0.01%
+4,510
New +$267K
INTC icon
269
Intel
INTC
$492B
$339K 0.01%
6,801
-400
-6% -$19.5K
AMZN icon
270
Amazon
AMZN
$3T
$313K 0.01%
1,920
– –
MSFT icon
271
Microsoft
MSFT
$3.76T
$311K 0.01%
1,400
– –
THRM icon
272
Gentherm
THRM
$1.27B
$294K 0.01%
+4,504
New +$243K
JPM icon
273
JPMorgan Chase
JPM
$956B
$286K 0.01%
2,249
– –
CTRE icon
274
CareTrust REIT
CTRE
$9.55B
$279K 0.01%
12,582
– –
ENOV icon
275
Enovis
ENOV
$1.4B
$277K 0.01%
4,205
– –
9 10
11
12 13

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.